Bain Capital Life Sciences Investors, LLC Top Holdings and 13F Report (2025) About Bain Capital Life Sciences Investors, LLCInvestment ActivityBain Capital Life Sciences Investors, LLC has $799.27 million in total holdings as of June 30, 2025.Bain Capital Life Sciences Investors, LLC owns shares of 23 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 12.60% of the portfolio was purchased this quarter.About 3.75% of the portfolio was sold this quarter.This quarter, Bain Capital Life Sciences Investors, LLC has purchased 24 new stocks and bought additional shares in 3 stocks.Bain Capital Life Sciences Investors, LLC sold shares of 2 stocks and completely divested from 2 stocks this quarter.Largest Holdings NewAmsterdam Pharma $194,123,082CIDARA THERAPEUTICS INC $121,808,123Nuvalent $110,426,472Pharvaris $58,139,506DIANTHUS THERAPEUTICS INC $46,244,318 Largest New Holdings this Quarter 98420X202 - X4 PHARMACEUTICALS INC $1,071,332 Holding Largest Purchases this Quarter CIDARA THERAPEUTICS INC 1,797,600 shares (about $87.56M)Cabaletta Bio 6,916,237 shares (about $10.51M)UPSTREAM BIO INC 144,216 shares (about $1.58M)X4 PHARMACEUTICALS INC 563,859 shares (about $1.07M) Largest Sales this Quarter Disc Medicine 400,000 shares (about $21.18M)DIANTHUS THERAPEUTICS INC 207,457 shares (about $3.86M) Sector Allocation Over TimeMap of 500 Largest Holdings ofBain Capital Life Sciences Investors, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorNAMSNewAmsterdam Pharma$194,123,0820.0%10,719,11024.3%MedicalCIDARA THERAPEUTICS INC$121,808,123$87,561,096 ▲255.7%2,500,68015.2%COM NEWNUVLNuvalent$110,426,4720.0%1,447,26713.8%MedicalPHVSPharvaris$58,139,5060.0%3,303,3817.3%MedicalDIANTHUS THERAPEUTICS INC$46,244,318$3,864,924 ▼-7.7%2,482,2505.8%COMSVRASavara$40,129,4160.0%17,600,6215.0%MedicalSLDBSolid Biosciences$38,529,8280.0%7,911,6694.8%MedicalIRONDisc Medicine$30,902,160$21,184,000 ▼-40.7%583,5003.9%MedicalOLMAOlema Pharmaceuticals$29,155,2440.0%6,843,9543.6%MedicalRPIDRapid Micro Biosystems$29,099,2320.0%8,434,5603.6%MedicalUPSTREAM BIO INC$26,786,127$1,583,492 ▲6.3%2,439,5383.4%COMCABACabaletta Bio$14,709,230$10,512,680 ▲250.5%9,677,1251.8%MedicalTNGXTango Therapeutics$13,885,4810.0%2,712,0081.7%MedicalANNXAnnexon$12,597,7660.0%5,249,0691.6%MedicalKYVERNA THERAPEUTICS INC$10,340,8960.0%3,368,3701.3%COMAVIRAtea Pharmaceuticals$8,948,2970.0%2,485,6381.1%MedicalXLOXilio Therapeutics$3,104,9790.0%4,566,8170.4%MedicalIPSCCentury Therapeutics$3,022,7690.0%5,410,3610.4%MedicalMRSNMersana Therapeutics$2,564,4470.0%8,663,6730.3%MedicalCCCCC4 Therapeutics$1,590,0310.0%1,111,9100.2%MedicalIVVDInvivyd$1,286,7100.0%1,799,5950.2%MedicalX4 PHARMACEUTICALS INC$1,071,332$1,071,332 ▲New Holding563,8590.1%COM NEWNAMSWNewAmsterdam Pharma$800,0000.0%100,0000.1%MedicalXFORX4 Pharmaceuticals$0$3,998,891 ▼-100.0%00.0%MedicalNAUTNautilus Biotechnology$0$923,354 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access